/Investor DB

Bios Partners — Full Portfolio

27 tracked investments · listed companies and verified rows first

Actuate Therapeuticsactuatetherapeutics.comin𝕏NASDAQ: ACTUSep 2015 · $21.7M

Actuate Therapeutics is a clinical-stage biopharmaceutical company developing elraglusib, a small-molecule GSK-3β inhibitor designed to treat difficult-to-treat cancers including pancreatic, melanoma, lung, and pediatric cancers through intravenous injection and oral tablet formulations.

BiotechFort Worth, US

Daniel Schmitt(President & Chief Executive Officer)Paul Lytle(Executive Officer)inAndrew Mazar(Executive Officer)

BoardTodd Thomson(Director)inRoger Sawhney(Director)Jason Keyes(Director)

Board seatAaron G.L. FletcherAaron G.L. FletcherLeslie W. Kreis, Jr.· per SEC Form D

Co-investorsIllinois VenturesKairos Venture Investments, LlcNuFund Venture GroupBiosDEFTA PartnersTech Coast Angels

Azitraazitrainc.comNYSE: AZTRSep 2020 · $17M

Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.

AI & Machine LearningBiotechHealthtechFarmington, US

Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)

BoardStella Robertson(Director)in

Board seatStella M. RobertsonTravis Whitfill· per SEC Form D

Co-investorsKdT VenturesConnecticut InnovationsLeaps by Bayer

Cue Biopharmacuebiopharma.cominNASDAQ: CUENov 2022SEC filingmedium confidence

Cue Biopharma is a precision immunotherapy company developing engineered therapies targeting allergic and autoimmune diseases.

BiotechHealthtechMedical DevicesBoston, US

Daniel Baker(Executive Officer)Colin Sandercock(Executive Officer)inDominic Borie(Chief Medical Officer and Head of Research and Development)inSumita Ray(Executive Officer)inMichael Meluzio(Executive Officer)inRodolfo Chaparro(Vice President, Head of Immunology)in

Board seatAaron G.L. Fletcher· per SEC Form D · $30M raise · filed Nov 2022

In8Bioin8bio.cominNASDAQ: INABMay 2018

IN8bio is a clinical-stage biopharmaceutical company developing gamma-delta T cell therapies for solid and hematological tumors using its DeltEx platform (allogeneic, autologous, iPSC, and genetically modified approaches).

BiotechHealthtechNew York, US

Lawrence Lamb(Scientific Founder & Chief Scientific Officer)inWilliam Ho(Founder & Chief Executive Officer)inKate Rochlin(Executive Officer)inPatrick McCall(Executive Officer)inTravis Whitfill(Director)inMelissa Beelen(Executive Officer)

Board seatTravis Whitfill· per SEC Form D

EquipmentShareequipmentshare.comin𝕏NASDAQ: EQPTSeed

EquipmentShare offers equipment rental along with fleet tracking software and hardware security tools for the construction industry.

Construction TechIoTPropTechSaaSColumbia, US

Brad Siegler(Founder)inJeff Lowe(Founder)inJabbok Schlacks(Founder)inWilliam Schlacks(President)inWilly Schlacks(Founder)Alex Levy(Investor)in

Co-investorsY CombinatorAmity VenturesDepth VenturesEvolution VC PartnersFundersClubG Squared+30 more

Lantern Pharmalanternpharma.comin𝕏NASDAQ: LTRN

Lantern Pharma is a pharmaceutical biotechnology company that applies machine learning and AI to oncology drug development, using data-driven hypothesis testing with in vitro and in vivo models.

AI & Machine LearningBiotechHealthtechDallas, US

Arunkumar Asaithambi(Director)David R. Margrave(Chief Financial Officer, Secretary)inPanna Sharma(Chief Executive Officer, President)inKishor G. Bhatia(Chief Scientific Officer)inDavid Keyser(Director)John Fucci(Director)

Co-investorsGreen Park & Golf VenturesHealth Wildcatters

Opus Geneticsopusgtx.cominNASDAQ: IRD

Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company developing therapies for inherited retinal diseases (IRDs) and other retinal and refractive disorders.

BiotechDeep TechDigital HealthHealthtechMedical DevicesRaleigh, US

Bernhard Hoffmann(Executive Officer)Nirav Jhaveri(Executive Officer)inAmy Rabourn(Executive Officer)inGeorge Magrath(Chief Executive Officer)inBen Yerxa(President)inRobert Gagnon(Chief Financial Officer)

Co-investorsMichigan Capital NetworkOberland Capital

Taysha Gene Therapiestayshagtx.comin𝕏NASDAQ: TSHA

Taysha Gene Therapies develops and commercializes gene therapies for monogenic diseases of the central nervous system, serving patients with rare and larger CNS conditions.

BiotechDeep TechDigital HealthHealthtechMedical DevicesTexas, US

R.A. Session II(Executive Officer, Director)inSean P. Nolan(Chief Executive Officer and Board Chairman)in

BoardPaul B. Manning(Director)in

Co-investorsGV (Google Ventures)BairdGoldman SachsJefferiesPBM Capital

Trefoil Therapeuticstrefoiltherapeutics.cominApr 2025✓ verified

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in

BoardChristy Shaffer(Director)inRalph Bradshaw(Director)

Board seatStella M. Robertson· per SEC Form D

Co-investorsExSight VenturesHatteras Venture PartnersSolasta VenturesAccess BiotechnologyCorrelation VenturesFemHealth Ventures+1 more

ONL Therapeuticsonltherapeutics.cominMar 2023✓ verified

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

David Zacks(Co-Founder & Chief Scientific Officer)inDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)John K Freshley(Executive Officer, Director)inJeffrey A Jamison(Executive Officer)in

BoardAaron Fletcher(Director)in

Co-investorsExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesInFocus Capital Partners, LLCJohnson & Johnson Innovation – JJDC+3 more

410 Medical410medical.comin𝕏Aug 2018SEC filingmedium confidence

410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation.

HardwareHealthtechMedical DevicesDurham, US

Mark Donald Piehl(Executive Officer, Director)KYLE CHENET(Executive Officer, Director)in

BoardJEFF TERRELL(Director)inSTANLEY D. LYNALL(Director)FRED GOLDWATER(Director)inMAYANK TANEJA(Director)in

Board seatTravis Whitfill· per SEC Form D · $4M raise · filed Aug 2018

Co-investorsBallad VenturesCU Healthcare Innovation FundDuke Capital PartnersHatteras Venture PartnersOSF VenturesWellstar+2 more

BobcatBiobobcatbio.comJul 2021

BiotechHummelstown, US

Stephen C. Rocamboli(Executive Officer, Director)inRifat Pamukcu(Director)Robert Towarnicki(Executive Officer, Director)Roger Sawhney(Director)

BoardJohn Fucci(Director)in

Board seatTim Van Treuren· per SEC Form D

Co-investorsBioAdvanceLife Sciences Greenhouse Investments

Lung Therapeuticslungtx.comMar 2022

BiotechAustin, US

James Brian Windsor(President and CEO)Steven Idell(Director)

BoardAaron Fletcher(Director)inJoseph Woelkers(Director)Robert Mills(Director)

Board seatAaron G.L. Fletcher· per SEC Form D

Co-investorsUT Horizon Fund

Actuateactuate.aiin𝕏May 2019 · $21.7M

Actuate provides AI-based video analytics that turn existing IP cameras and NVRs into a security detection system, offering real-time alerts for threats such as intruders, loitering, guns, and crowds.

AI & Machine LearningCloud ComputingCybersecurityGovTechSaaS

Sonny Tai(Co-Founder)inKen Francis(CEO)in

Co-investorsBling CapitalDorm RoomGray Line PartnersMetaPropMetaProp VenturesScribble Ventures+4 more

Bluesmartbluesmart.comSeedAcquired

Bluesmart is a travel company that makes app-connected smart luggage for travelers.

ConsumerHardwareIoTTravel & HospitalityNew York City, US

Alejo Verlini(CPO)inDiego Saez Gil(CEO)inMartin Diz(CTO)inTomi Pierucci(CEO)Brian Chen(Vice President of Operations)Pablo Orlando(COO)in

Co-investorsY CombinatorCota CapitalFundersClubGerman VenturesMind the Seed - MTS FundACE & Company+18 more

Call9callnine.comSeries ADefunct

Call9 provides emergency medicine and palliative care at patients' bedsides within skilled nursing facilities, using a proprietary platform that connects onsite Clinical Care Specialists with offsite emergency medicine physicians who diagnose and treat patients remotely.

Digital HealthHealthtechMedical DevicesNew York City, US

Celina Tenev(Founder)Timothy Peck(CEO)XiaoSong Mu(CTO)Chris Stringfellow

Co-investorsFundersClubY CombinatorGreat Oaks Venture CapitalHillcrest Venture PartnersIndex VenturesJoe Lonsdale+8 more

Cognition Therapeuticscogrx.comin𝕏

Cognition Therapeutics is a clinical-stage biotechnology company developing zervimesine (CT1812), an investigational once-daily oral small-molecule therapy designed to protect brain synapses by blocking toxic protein oligomers.

BiotechHealthtechPittsburgh, US

Susan Catalano(Executive Officer, Director)inSusan Catalano, Ph.D.(Co-founder)Lisa Ricciardi(Chief Executive Officer)inHarold Safferstein(Executive Officer, Director)

BoardNada Jain(Director)Franz Hefti(Director)

Co-investors3E Bioventures CapitalArieal Southeast Angel PartnersAtlanta Technology AngelsCowtown AngelsDolby Family VenturesGolden Seeds+2 more

Convoxconvox.comin𝕏Seed · Aug 2015Acquired

Convox provides a platform for deploying and managing cloud-native applications across multiple cloud providers including AWS, Google Cloud, and Azure.

Cloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareAtlanta, US

David Dollar(CEO)inNoah Zoschke(CTO)inMatt Manning(Founder)in

Co-investorsCurious CapitalGarage CapitalHeavybitY CombinatorInovia CapitalProsperity7 Ventures+4 more

Encore Vision Inc.encorevisionusa.com

Encore Vision supplies eyewear frames and operates a full-service digital optical lab, offering combined frame-and-lens solutions to eyecare practices.

HealthtechRetail TechFort Worth, US

Evelyn Blake(Executive Officer)William R. Burns(Executive Officer, Director)in

BoardLes Kreis(Director)Robert Willard(Director)John Hunkeler(Director)Adrienne Graves(Director)

Co-investorsCowtown Angels

i-Lumen Scientific, Inc.i-lumen.com

i-Lumen Scientific develops a non-invasive bioelectric therapy aimed at restoring retinal electrophysiology in patients with intermediate to advanced dry age-related macular degeneration (AMD).

BiotechHealthtechMedical Devices

Pomellopomello.comSeedAcquired

Pomello provides analytics software that maps a company's organizational culture team-by-team and integrates with existing recruiting processes to identify candidates likely to thrive in the organization.

AI & Machine LearningEnterprise SoftwareHR TechSaaSSan Francisco, US

Oliver Staehelin(Founder)inCatherine Spence(Founder)inXian Ke

Co-investorsSoma CapitalY CombinatorChina Growth CapitalHaystackNew Enterprise Associates (NEA)PreAngel Fund

Stream Biomedicalstreambiomedical.comDec 2021

Stream Biomedical is a clinical-stage biotechnology company developing LG3, a biologic derived from a natural repair protein intended to protect and restore the brain by activating its repair systems.

BiotechDeep TechHealthtechHouston, US

H. Davis Adkisson(Chief Scientific Officer)inChris Garabedian(Director)William Schwieterman(Board of Directors)Fred Callori(Director)

BoardAmanda De La Garza(Director)in

Co-investorsCowtown Angels

Yhatyhat.cominSeedAcquired

Yhat provided a platform for managing the complete lifecycle of data science projects, from model development through deployment.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareNew York City, US

Austin Ogilvie(CEO)inGreg Lamp(Founder)inRyan O'Neil(Lead Engineer)in

Co-investorsboldstart venturesContour Venture PartnersLongley CapitalRRE VenturesY CombinatorCollaborative Fund+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

SIRPant Immunotherapeutics, Inc.Immusoft CorporationRein TherapeuticsRenibus Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.